Small Molecules
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
15
NCT05516121
VLT-015 in Patients With Schizophrenia
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 1, 2021
Completion: Oct 30, 2022
Loading map...